KPW
CRL icon

Kore Private Wealth’s Charles River Laboratories CRL Stock Holding History

Kore Private Wealth’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-95
Closed -$16K – 444
2020
Q2 		$16K Buy
+95
New +$15.2K ﹤0.01% 697

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kore Private Wealth's CRL Position: Q3 2020 in Review

Kore Private Wealth sold out of Charles River Laboratories (CRL) in Q3 2020, closing a stake of 95 shares — an estimated $16K sold.

Kore Private Wealth first reported a position in CRL in Q2 2020 and held it in 1 quarter. The position peaked at $16K in Q2 2020. 492 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

  • Kore Private Wealth reported no remaining Charles River Laboratories position as of Q3 2020 after selling out during the quarter.
  • Kore Private Wealth sold 95 Charles River Laboratories shares in Q3 2020, an estimated $16K.
  • Kore Private Wealth first reported a position in Charles River Laboratories in Q2 2020 and held it in 1 quarter.
  • Kore Private Wealth's Charles River Laboratories position peaked at $16K in Q2 2020.
  • 492 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.